Literature DB >> 33301833

METTL14 mediated m6A modification to LncRNA ZFAS1/ RAB22A: A novel therapeutic target for atherosclerosis.

Chengwu Gong1, Yun Fan2, Jichun Liu3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33301833     DOI: 10.1016/j.ijcard.2020.12.002

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  6 in total

Review 1.  m6A Methylation in Cardiovascular Diseases: From Mechanisms to Therapeutic Potential.

Authors:  Longbo Li; Nannan Xu; Jia Liu; Zhenzhen Chen; Xu Liu; Junnan Wang
Journal:  Front Genet       Date:  2022-06-28       Impact factor: 4.772

2.  The m6A methyltransferase METTL3 affects autophagy and progression of nasopharyngeal carcinoma by regulating the stability of lncRNA ZFAS1.

Authors:  Jiaojiao Peng; Hong Zheng; Feng Liu; Qi Wu; Shixi Liu
Journal:  Infect Agent Cancer       Date:  2022-01-03       Impact factor: 2.965

3.  METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA.

Authors:  Liping Meng; Hui Lin; Xingxiao Huang; Jingfan Weng; Fang Peng; Shengjie Wu
Journal:  Cell Death Dis       Date:  2022-01-10       Impact factor: 8.469

Review 4.  Emerging roles of the RNA modifications N6-methyladenosine and adenosine-to-inosine in cardiovascular diseases.

Authors:  Vilbert Sikorski; Antti Vento; Esko Kankuri
Journal:  Mol Ther Nucleic Acids       Date:  2022-07-20       Impact factor: 10.183

Review 5.  The role of RNA m6A methylation in lipid metabolism.

Authors:  Yuting Wang; Yujie Wang; Jiarui Gu; Tianhong Su; Xiaosong Gu; Yu Feng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-08       Impact factor: 6.055

Review 6.  The molecular mechanism of METTL3 promoting the malignant progression of lung cancer.

Authors:  Chao Ma; Rui-Jie Ma; Kang Hu; Qi-Ming Zheng; Ye-Peng Wang; Nan Zhang; Zhi-Gang Sun
Journal:  Cancer Cell Int       Date:  2022-03-24       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.